La cadena de opciones muestra datos clave de las opciones de acciones de Sportradar Gr a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Sportradar Gr..

Sportradar Gr (NASDAQ:SRAD) Bolsa, Cadena de Opciones

Sportradar Gr

Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.

Sportradar Group AG - Class A Ordinary Shares

Sportradar Group AG

News

Analyst Ratings

Trading Ideas

Live On CNBC, Stephanie Link Announces Sold The Home Depot, Inc.

WIIM

VVPR

VivoPower International shares are trading higher after the company announced the date for its special dividend distributions related to the Tembo transactions.

UBER

Live On CNBC, Stephanie Link Announces Bought Uber Technologies

REGN

Regeneron Pharmaceuticals shares are trading higher. A company executive reportedly said the 23andMe auction process was recently reopened and that the tariff situation is not "material" to the business.

Plug Power Form4 Filing Shows Paul B Middleton Bought 650,000 Shares At An Average Price Of $1.03/Share

Ohmyhome Shares Halted On Circuit Breaker To The Upside, Stock Now Up 92.2%

Morgan Stanley analyst Matthew Cost maintains AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) with a Overweight and raises the price target from $420 to $460.

Price Target

Morgan Stanley Maintains Overweight on AppLovin, Raises Price Target to $460

The U.S. Food and Drug Administration (FDA) sent a &#8220;refusal to file&#8221; letter to Axsome Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) on Monday regarding its AXS-14 (esreboxetine) treatment <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">of fibromyalgia</a>.
The FDA states that upon preliminary review, the New Drug Application (NDA) was not sufficiently complete to <a href="https://www.benzinga.com/pressreleases/25/06/g45832920/axsome-therapeutics-provides-update-on-the-new-drug-application-nda-for-axs-14-for-the-management-" target="_blank" rel="noreferrer noopener">permit a substantive review</a>.
Fibromyalgia is a chronic disorder characterized by widespread pain, fatigue, disturbed sleep, depression, and cognitive impairment.
Approximately 17 million Americans, 90% of whom are women, are estimated to suffer from fibromyalgia.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44587826/axsomes-solriamfetol-fails-primary-goal-in-depression-study-but-shows-improvements-in-associated-sleep-disorder" rel="noreferrer noopener">Axsome&#8217;s Solriamfetol Fails Primary Goal In Depression Study But Shows Improvements In Associated Sleep Disorder</a>
Specifically, the FDA does not consider the second of the two placebo-controlled trials in the submission adequate and well-controlled because its primary endpoint was at 8 weeks, and it used a flexible-dose paradigm.
The FDA indicated that the first of the two placebo-controlled trials in the submission, which utilized a 12-week endpoint and a fixed-dose paradigm, is adequate and well-controlled.
The FDA did not raise any questions relating to the positive results of the studies, both of which met their primary endpoints.
To address the FDA&#8217;s feedback, Axsome will conduct an additional controlled trial. As requested by the FDA, this trial will use a fixed-dose paradigm and a 12-week primary endpoint. Axsome anticipates initiating this trial in the fourth quarter of 2025.
Axsome CEO Herriot Tabuteau said the company is &#8220;well positioned to initiate a new controlled trial that will incorporate the FDA&#8217;s feedback by the end of 2025.&#8221;
While the RTF is disappointing, William Blair had ascribed only $3.38 for the AXS-14 fibromyalgia program to total $199.98 sum-of-the-parts fair value in the model.
With the requirement for an additional study, analyst Myles Minter has delayed the launch of AXS-14 in the model to the second half of 2028 and now ascribes $1.89 for the program to the fair value.
Investor focus remains on the Alzheimer's disease agitation (AD-A), which is on track for the third quarter of 2025.
After talking with the company's management, William Blair said they believe the recent Refusal to File (RTF) is limited to the Division of Anesthesiology, Addiction Medicine, and Pain Medicine and the fibromyalgia program.
It should not impact the separate submission for AXS-05 in Alzheimer's disease agitation, which will go through the Psychiatry division in Q3 2025. 
The firm added that getting a PDUFA date for this application, supported by the ADVANCE and ACCORD studies, and possibly receiving priority review due to its breakthrough therapy status, would be a key milestone and help reduce concerns about FDA-related delays caused by its internal restructuring.
Price Action: AXSM stock is down 0.60% at $111.24 at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/02/43790716/axsomes-axs-05-in-alzheimers-agitation-could-be-billion-dollar-opportunity-says-analyst" target="_blank" rel="noreferrer noopener">Axsome&#8217;s AXS-05 In Alzheimer&#8217;s Agitation Could Be Billion Dollar Opportunity, Says Analyst</a></li>
</ul>
Image: Shutterstock

Analyst Color

Biotech

Health Care

General

AXSM

FDA Pushes Pause On Axsome Fibromyalgia Drug, New Trial Required

Morgan Stanley analyst John Glass downgrades McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) from Overweight to Equal-Weight and lowers the price target from $329 to $324.

Downgrades

Morgan Stanley Downgrades McDonald's to Equal-Weight, Lowers Price Target to $324

Academy Sports and Outdoors, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) will release its first-quarter financial results before the <a href="https://www.benzinga.com/quote/ASO">opening bell on Tuesday, June 10.</a>
Analysts expect the Katy, Texas-based company to report quarterly earnings at 89 cents per share, down from $1.08 per share in the year-ago period. Academy Sports and Outdoors projects quarterly revenue of $1.37 billion, compared to $1.36 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 6, Academy Sports and Outdoors declared a quarterly cash dividend of 13 cents per share.
Academy Sports and Outdoors shares gained 2% to trade at $44.31 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/aso/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Citigroup analyst Paul Lejuez maintained a Buy rating and cut the price target from $60 to $55 on June 4, 2025. This analyst has an accuracy rate of 64%.</li>
<li>UBS analyst Michael Lasser maintained a Neutral rating and slashed the price target from $54 to $48 on June 4, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and raised the price target from $38 to $43 on May 14, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Evercore ISI Group analyst Greg Melich maintained an In-Line rating and cut the price target from $54 to $53 on April 1, 2025. This analyst has an accuracy rate of 81%.</li>
<li>JP Morgan analyst Christopher Horvers maintained a Neutral rating and raised the price target from $52 to $54 on March 21, 2025. This analyst has an accuracy rate of 71%</li>
</ul>
Considering buying ASO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ASO/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="407" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09123435/image-121-1024x407.png" alt="" class="wp-image-943539" style="width:577px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09123435/image-121-1024x407.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09123435/image-121-300x119.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09123435/image-121-768x305.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09123435/image-121.png 1501w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/45835438/top-3-financial-stocks-that-may-collapse-in-june">Top 3 Financial Stocks That May Collapse In June</a> </li>
</ul>
Photo via Shutterstock

Markets

Top Wall Street Forecasters Revamp Academy Sports and Outdoors Expectations Ahead Of Q1 Earnings

Morgan Stanley analyst Erin Wright initiates coverage on Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) with a Overweight rating and announces Price Target of $364.

Initiation

Morgan Stanley Initiates Coverage On Molina Healthcare with Overweight Rating, Announces Price Target of $364

Morgan Stanley analyst Ricky Goldwasser initiates coverage on Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) with a Overweight rating and announces Price Target of $70.

Morgan Stanley Initiates Coverage On Centene with Overweight Rating, Announces Price Target of $70

NCPL

Netcapital shares are trading higher following the announcement that its portfolio company, Zelgor, has completed the acquisition of Mixie.

Morgan Stanley analyst Alexandra Steiger downgrades Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from Overweight to Equal-Weight and lowers the price target from $346 to $280.

LULU

Morgan Stanley Downgrades Lululemon Athletica to Equal-Weight, Lowers Price Target to $280

SCHW

The Schwab Trading Activity Index Decreased To 39.68 In May, Down From Its Score Of 41.18 In April

Morgan Stanley analyst Dara Mohsenian reiterates Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) with a Overweight and maintains $81 price target.

Reiteration

Morgan Stanley Reiterates Overweight on Coca-Cola, Maintains $81 Price Target

Real estate investor Grant Cardone has navigated multiple economic downturns and can spot trends before most investors notice. He's been highlighting the growing trend of <a href="https://www.tiktok.com/@grantcardone/video/7512161619372166430?lang=en">renting over owning property</a> and explained some of the factors that have led to this change.
"Many people don't want to commit to 30 years. They're on the move," Cardone said.
Cardone mentioned housing prices, shortcomings of the Biden administration, and other details when painting the picture of America becoming a renter nation.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.</li>
</ul>
<h2 class="wp-block-heading">A Rolling Recession</h2>
Cardone believes we were in a recession during the Biden administration that wasn&#8217;t properly covered because the definition of a recession was changed. He stated that the U.S. experienced multiple back-to-back quarters of declining GDP, and job numbers only looked decent because 40%-45% of all added jobs were government jobs during the Biden administration.
Cardone mentioned this context since people are more likely to rent than buy during recessions. Mortgages become less accessible during recessions, and people don't have the money to keep up with living costs and save up for a down payment.
He also stated that some people are waiting for housing prices to go down. That's a common strategy during economic contractions, as people hope to buy at a lower price in a few months. Some potential home buyers have no problem with waiting for more affordable prices, and that has resulted in higher demand for the rental market.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">More People Are Living Mobile Lifestyles</h2>
Cardone also mentioned that people are being more mobile instead of sticking to one place. This lifestyle makes it easier for people to get up and move to another city. Cardone is a fan of moving every once in a while. He moved from Louisiana to San Diego before moving to Los Angeles and finally Miami, where he currently resides.&nbsp;
Cardone believes you should relocate if you get too comfortable and seem to know everyone in the area. It seems like more people are following up on that advice by renting instead of buying.&nbsp;
Cardone specifically mentioned California and said that less than 16% of Californians own a home. He said that many of them cannot afford it due to high housing costs and the difficulty of qualifying for a mortgage. Getting a mortgage becomes even more difficult when houses are valued at millions of dollars.
See Also: Wall Street's Missing This AI Surgical Tech — You Don't Have To.<a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution"> Invest from $350.</a>
<h2 class="wp-block-heading">Housing Is Expensive</h2>
Although you're not building equity when you pay rent, housing isn't free either. Even after paying off the mortgage, you still have to contend with property taxes, repairs, and other homeownership costs. Cardone is on record saying that a primary residence is not a good investment.
Investors might generate higher returns if they put their money into the stock market instead of putting a down payment toward a primary residence. While it's advantageous to have a paid-off mortgage when you retire, your funds might grow faster if you put them to work in better investments.
The debate on buying vs. renting from an investment standpoint mainly applies to people who can afford housing. Cardone mentions that the Biden administration increased the country's debt by $8.4 trillion, and additional increases to the federal debt will make housing and all resources less affordable. Any additional debt causes the purchasing power of the U.S. dollar to decrease.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

Grant Cardone Explains Why We Are Becoming A Renter Nation: 'Many People Don't Want To Commit To 30 Years. They're On The Move.'

NRG Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) has outperformed the market over the past 5 years by 21.46% on an annualized basis producing an average annual return of 36.0%. Currently, NRG Energy has a market capitalization of $30.67 billion. 
Buying $100 In NRG: If an investor had bought $100 of NRG stock 5 years ago, it would be worth $464.05 today based on a price of $156.85 for NRG at the time of writing.
<h3>NRG Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749486612_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In NRG Energy 5 Years Ago Would Be Worth Today

Anthony Pompliano, founder of Professional Capital Management, said he sees stablecoins as one <a href="https://www.benzinga.com/money/bitcoin-price-prediction">key driver for the growth </a>of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: Speaking in an <a href="https://www.youtube.com/watch?v=pZ1hlWlYBTk">interview</a> with CNBC on June 9, he pointed to companies like Gemini and Robinhood (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) as examples of platforms adapting their business models to serve both crypto-native and mainstream users.
Retail investors, he noted, now account for roughly 36%–38% of U.S. equities ownership, and many of them have been shaped by the crypto market's volatility. 
This has instilled a strong "buy the dip" mentality among the new generation of traders.
Bitcoin's Future: Hyper-Bitcoinization
Pompliano distinguished between the roles of stablecoins and Bitcoin: stablecoins are ideal for transactions and spending, while Bitcoin currently serves as a digital savings account. 
Over time, however, he believes Bitcoin could take on both functions, a transformation he describes as "Hyper-Bitcoinization." In this scenario, Bitcoin becomes globally accepted not just as a store of value, but also as a widely used medium of exchange.
While this transition is still years away, he sees it as Bitcoin's "final form."
Stablecoins Gaining Ground
Pompliano also discussed the growing stablecoin ecosystem, noting differences in strategy between issuers like Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) and Circle (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>). 
He suggested that stablecoins which return yield from underlying assets could become increasingly attractive and mentioned ongoing innovation to bring stablecoins onto Bitcoin's blockchain, signaling a broader expansion of Bitcoin's utility.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45833498/bitcoin-ethereum-xrp-dogecoin-start-the-week-green-ahead-of-us-china-trade-talks">Bitcoin, Ethereum, XRP, Dogecoin Start The Week Green Ahead Of US-China Trade Talks</a>
Why It Matters: Pompliano believes that stablecoin companies like Circle are well-positioned to succeed in public markets due to their compatibility with traditional finance systems. 
However, he cautioned that broader success will depend on business fundamentals, not simply being a crypto firm.
He also touched on the impact of macroeconomic volatility, referencing recent geopolitical moves like fluctuating tariffs. These dynamics, he argued, are increasingly relevant as crypto becomes more integrated with the global financial system.
As this integration deepens, crypto assets, particularly Bitcoin, are likely to become more sensitive to traditional economic and geopolitical trends.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45835021/bitcoin-pushes-to-107000-as-pivotal-resistance-level-gets-tested-once-again">Bitcoin Pushes To $107,000 As Pivotal Resistance Level Gets Tested Once Again</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$USDC

$USDT

HOOD

Anthony Pompliano Says Bitcoin's Endgame Is Hyper-Bitcoinization

Melius Research analyst Rob Wertheimer initiates coverage on Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) with a Buy rating and announces Price Target of $213.

Melius Research Initiates Coverage On Waste Connections with Buy Rating, Announces Price Target of $213

Press Releases

Sportradar Announces Agreement to Acquire IMG ARENA and Its Strategic Portfolio of Global Sports Betting Rights

Earnings

Sportradar Reports Fourth Quarter and Full Year 2024 Results and Announces Agreement to Acquire IMG Arena and Its Strategic Portfolio of Global Sports Betting Rights

Sportradar Files Its Annual Report on Form 20-F

Sportradar Outlines Growth Strategy and Financial Outlook at Investor Day

Sportradar Announces Launch of Public Offering of Class A Ordinary Shares by Selling Shareholders and Concurrent Share Repurchase

Sportradar Announces Preliminary First Quarter 2025 Financial Results

Sportradar Announces Pricing of Public Offering of Class A Ordinary Shares by Selling Shareholders and Concurrent Share Repurchase

Sportradar Reports First Quarter Results

Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025

AMCX

BATRA

CHDN

GENI

LION

MSGS

NXST

RSVR

SBGI

SRAD

TGNA

TSX:RCI

Needham

Morgan Stanley

Benchmark

BTIG

Screenshot 2025-05-29 at 11.55.03 PM

Sports Betting

Emerging Markets

Pushing The Boundaries Of Innovation: How Sportradar Is Setting New Industry Standards

Screenshot 2025-05-20 at 9.13.29 PM

From Concierge Style Sports Betting To AI Suggestions, Sportradar Takes Innovation to The Next Level

Screenshot 2025-03-25 at 5.32.08 PM

Revolutionizing Fan Engagement With Sportradar

Screenshot 2025-02-27 at 7.12.33 PM

The Future Of Sports Betting? Sportradar Technology Fuels Multi-Billion Dollar In-Play Industry

Screenshot 2025-02-20 at 7.39.13 PM

GOOG

Betting On The Future: How Sportradar Merges Sports, AI And Fan Engagement

Untitled design - 2024-12-09T182217.813

Sports

Sportradar Partners With The NBA To Help Bring A New Era Of Sports Viewership To Fans

Comments

Sportradar Gr

Sportradar Gr (SRAD) Opciones

Sportradar Gr (NASDAQ:SRAD) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL